Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK

Dixon, Giles; Hague, Samuel; Mulholland, Sarah; Adamali, Huzaifa; Khin, Aye Myat Noe; Thould, Hannah; Connon, Roisin; Minnis, Paul; Murtagh, Eoin; Khan, Fasihul; Toor, Sameen; Lawrence, Alexandra; Naqvi, Marium; West, Alex; Coker, Robina K.; Ward, Katie; Yazbeck, Leda; Hart, Simon; Garfoot, Theresa; Newman, Kate; Rivera-Ortega, Pilar; Stranks, Lachlan; Beirne, Paul; Bradley, Jessica; Rowan, Catherine; Agnew, Sarah; Ahmad, Mahin; Spencer, Lisa G.; Aigbirior, Joshua; Fahim, Ahmed; Wilson, Andrew M.; Butcher, Elizabeth; Chong, Sy Giin; Saini, Gauri; Zulfikar, Sabrina; Chua, Felix; George, Peter M.; Kokosi, Maria; Kouranos, Vasileios; Molyneaux, Philip; Renzoni, Elisabetta; Vitri, Benedetta; Wells, Athol U.; Nicol, Lisa M.; Bianchi, Stephen; Kular, Raman; Liu, HuaJian; John, Alexander; Barth, Sarah; Wickremasinghe, Melissa; Forrest, Ian A.; Grimes, Ian; Simpson, A. John; Fletcher, Sophie V.; Jones, Mark G.; Kinsella, Emma; Naftel, Jennifer; Wood, Nicola; Chalmers, Jodie; Crawshaw, Anjali; Crowley, Louise E.; Dosanjh, Davinder; Huntley, Christopher C.; Walters, Gareth I.; Gatheral, Timothy; Plum, Catherine; Bikmalla, Shiva; Muthusami, Raja; Stone, Helen; Rodrigues, Jonathan C.L.; Tsaneva-Atanasova, Krasimira; Scotton, Chris J.; Gibbons, Michael A.; Barratt, Shaney L.

doi:10.1183/23120541.00529-2023

All Outputs (2)

Opioids bring peace to patients with IPF cough (2024)
Journal Article
Sykes, D. L., & Hart, S. P. (in press). Opioids bring peace to patients with IPF cough. The lancet. Respiratory medicine, https://doi.org/10.1016/s2213-2600%2823%2900467-8

Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK (2024)
Journal Article
Dixon, G., Hague, S., Mulholland, S., Adamali, H., Khin, A. M. N., Thould, H., …Barratt, S. L. (2024). Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK. ERJ Open Research, 10(1), Article 00529-2023. https://doi.org/10.1183/23120541.00529-2023

Background Nintedanib slows progression of lung function decline in patients with progressive fibrosing (PF) interstitial lung disease (ILD) and was recommended for this indication within the United Kingdom (UK) National Health Service in Scotland in... Read More about Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK.